Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Phase 1 Completed 31 enrolled AstraZeneca Quintiles, Inc. · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of food on the pharmacokinetics (PK) of a single dose of AZD1775 (printed capsules) in patients with advanced solid tumours.

Timeline

Start: 2017-09-29
Primary completion: 2018-04-05
Completion: 2018-04-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adavosertib	Small molecule	300 mg	Oral

Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Summary

Timeline

Drugs

Indications